Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib is effective and safe for treating alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.